aapl

Larry Schutts
- http://www.stockwinners.com

Larry Schutts, a former university professor, is vice president of Stockwinners.com and a contributing editor for Theflyonthewall.com. Larry looks for stocks with technical and fundamental characteristics indicating gains in the next 30 days. However, price movements may be volatile. He includes a stop-loss price in each post. Consider selling a position should the stop-loss be violated.

Edwards Lifesciences Corporation (NYSE: EW) provides products and technologies designed to treat cardiovascular diseases. Offerings include tissue heart valves, valve repair products, heart monitoring equipment, central venous access devices and cardiac surgery system products. The company sells its goods through a direct sales force and independent distributors worldwide. Formerly part of Baxter International (NYSE: BAX), the firm was a year 2000 spin-off.

Edwards surprised the Street late last month, when it reported Q1 EPS of 56 cents and revenues of $296.8 million. Analysts had been expecting 49 cents and $284.4 million. In discussing the results, the CEO noted the success of new products and strong international sales growth. Management also guided Q2 EPS to 62-66 cents (58 cent consensus), FY08 EPS to $2.45-$2.53 ($2.35 consensus) and FY08 revenues to $1.210-$1.260 billion ($1.18B consensus).

Bally Technologies (NYSE: BYI) designs, manufactures, operates and distributes advanced gaming devices and associated information systems. Products include reel-spinning slot machines, video slots, wide-area progressives and lottery games, as well as an array of casino management, slot accounting, bonusing, cashless operation and table management systems. Bally also owns and operates the Rainbow Casino in Vicksburg, Mississippi.

The company pleased investors earlier in the week, when it announced fiscal Q3 EPS of 52 cents and revenues of $232.6 million. Analysts had been expecting 48 cents and $231 million. Operating income increased to 24% of revenue from 10% in the comparable period last year and from 20% in the December 2007 quarter. Management also guided FY08 EPS to $1.78-$1.90 ($1.79 consensus), FY08 revenues to levels above $885 million ($894.02M consensus) and FY09 EPS to $2.10-$2.50 ($2.24 consensus).

Priceline.com (NASDAQ: PCLN) is an online travel agency. It offers a range of services, including airline tickets, hotel rooms, car rentals, vacation packages and cruises, as well as destination and travel insurance services. The company operates a Name Your Own Price system, which allows users to make offers for travel services at prices they set. It also markets fixed-price travel products and offers various online financial services. Expedia (NASDAQ: EXPE) is a major competitor.

The firm pleased investors last week, when it reported Q1 EPS of 76 cents and revenues of $403.20 million. Analysts had been expecting 60 cents and $377.17 million. Gross travel bookings increased 76% yr/yr, a result above company guidance of 60-65%. Pro forma gross profit rose 74.7% yr/yr, versus guidance of 55-60%. Management predicted FY08 EPS of $5.25-$5.65 ($5.12 consensus).

RealNetworks (NASDAQ: RNWK) delivers digital information and entertainment. The firm's RealPlayer product downloads and streams audio, video, and other multimedia content. Its RealOne software and subscription service provides access to news, sports and entertainment content. Its Rhapsody digital music service delivers more than 1 billion songs per year. Its RealArcade is one of the largest casual games destinations on the Web. The company also assists businesses with tools for creating, delivering, and licensing digital content. Apple (NASDAQ: AAPL), Microsoft (NASDAQ: MSFT) and Yahoo (NASDAQ: YHOO) are competitors.

The firm pleased investors last week, when it reported Q1 EPS of two cents and revenues of $147.6 million. Analysts had been looking for a loss of three cents and $141.6 million. Management also guided Q2/FY08 estimates above consensus views, announced a $50 million share repurchase program and said it intended to spin off its global casual games business. Kaufman Brothers reiterated its "buy" rating on the shares and boosted its price target to $9.

Triumph Group (NYSE: TGI) designs, engineers, manufactures, repairs, overhauls and distributes aircraft components, such as hydraulic, mechanical and electromechanical control systems, aircraft and engine accessories, structural assemblies, auxiliary power units and aircraft instruments. Customers include original equipment makers and aftermarket manufacturers in the commercial, military, and air cargo markets.

The firm surprised the Street earlier in the month, when it reported Q4 EPS of $1.26 and revenues of $321.2 million. Analysts had been looking for $1.04 and $302.1 million. Management also guided FY08 EPS to $4.85-$5.05 ($4.12 consensus) and FY08 revenues to $1.25-$1.35 billion ($1.13 billion consensus). The CEO noted that quarterly sales had set a new company record and that backlog had reached a record $1.3 billion.

Mindray Medical International (NYSE: MR) is a Chinese manufacturer of medical equipment. It offers a variety of patient monitoring devices, diagnostic laboratory instruments and ultrasound imaging systems to clinics, hospitals and other health care providers in China and abroad. Mindray is headquartered in Shenzhen and operates sales/service offices in Asia, Europe and the Americas.

The firm pleased investors last week, when it reported Q1 EPS of 23 cents and revenues of $89.3 million. Analysts had been looking for 19 cents and $84.4 million. The CEO attributed success in the quarter to a high level of international activity and more the forty percent growth in domestic sales. Management also guided FY08 revenues to $560-$580 million ($454.88M consensus).

Syniverse Holdings (NYSE: SVR) provides a variety of technology services to wireless telecommunications companies. Those services enable phone number portability; fraud management; the invoicing and settlement of wireless roaming calls; and the routing and translation of services between carriers. The company also offers data clearing and financial clearing services. Customers include AT&T (NYSE: T), Sprint Nextel (NYSE: S) and Verizon Communications (NYSE: VZ).

The firm pleased investors last week, when it reported Q1 EPS of 37 cents and revenues of $115.6 million. Analysts had been looking for 26 cents and $102.4 million. In discussing the quarter, the CEO noted particular strength in messaging and mobile data. Management also guided FY08 revenues to $455-$465 million ($435.83M consensus). JP Morgan subsequently upgraded the shares to "overweight". Wedbush Morgan reiterated its "strong buy," Lehman Brothers its "overweight" and Brean Murray its "buy." Price targets ranged between $24 and $26.

ON Semiconductor (NASDAQ: ONNN) designs and manufactures a wide variety of power and data management semiconductors for customers in the automotive, communications, computer, medical, industrial and military/aerospace markets. It operates a network of manufacturing facilities, sales offices and design centers in key markets throughout North America, Europe and the Asia Pacific region. Top clients include Nokia (NYSE: NOK) and Sony (NYSE: SNE). Texas Instruments (NYSE: TXN) is a major competitor.

The firm pleased investors last week, when it reported Q1 EPS of 21 cents and revenues of $421.9 million. Analysts had been looking for 14 cents and $386.9 million. Management also guided Q2 revenues to $545-$560 million ($400.6M consensus). Canaccord Adams subsequently upgraded the shares to "buy". Kaufman Brothers, Lehman Brothers and Wedbush Morgan reiterated their "buy" ratings.

Natus Medical (NASDAQ: BABY) makes products for the detection, treatment, monitoring and tracking of common medical disorders in babies. Ailments addressed include hearing impairment, neurological dysfunction, epilepsy, sleep disorders, newborn jaundice and metabolic disorders. In addition, the company makes neonatal oxygen delivery hoods and heatshields. It also provides software that collects and reports newborn screening data to health labs and disease control centers.

The firm pleased investors earlier in the month, when it reported Q1 EPS of 11 cents and revenues of $36.9 million. Analysts had been looking for 10 cents and $35.5 million. The CEO particularly noted strong sales of the company's newborn hearing screening products. Management also guided Q2 EPS to 14-15 cents (14 cent consensus), Q2 revenues to $38-$39 million ($38.23M consensus), FY08 EPS to 70-72 cents (67 cent consensus) and FY08 revenues to $161-$162 million ($159.58M consensus).

Sykes Enterprises (NASDAQ: SYKE) provides outsourced customer contact management services to the business community. It offers technical support and customer service via telephone, e-mail and chat, through centers in the Americas, Europe, Asia and Africa. Sykes also provides large corporations with technical staffing and customer relationship management consulting services. Clients are primarily firms in the communications, technology, financial services, healthcare and transportation industries.

The company pleased investors last week, when it announced Q1 EPS of 38 cents and revenues of $203.7 million. Analysts had been looking 26 cents and $201.6 million. Management also guided Q2 EPS to 29-31 cents (27 cent consensus), Q2 revenues to $205-$210 million ($200.34M consensus), FY08 EPS to $1.24-$1.33 ($1.15 consensus) and FY08 revenues to $815-$830 million ($815.04M consensus). Susquehanna Financial subsequently reiterated its "positive" rating on the shares.

eResearchTechnology (NASDAQ: ERES) provides technology and services to the pharmaceutical, biotechnology and medical device industries. The company streamlines the clinical trials process by enabling customers to automate the collection, analysis and distribution of data in all phases of clinical development. The firm's flagship product, EXPeRT, processes and interprets electrocardiogram data collected during trials, to insure cardiac safety. eResearchTechnology operates in the US and the UK.

The firm pleased investors earlier in the week, when it reported Q1 EPS of 11 cents and revenues of $33.7 million. Wall Street analysts had been looking for nine cents and $31.6 million. Management also guided Q2 EPS to 10-12 cents (ten cent Street), Q2 revenues to $34-$36 million ($32.95M Street), FY08 EPS to 44-49 cents (44 cent Street) and FY08 revenues to $133-$140 million ($134.99M Street). Friedman Billings subsequently reiterated its "outperform" rating on the shares and boosted its price target to $18.

Airgas Inc. (NYSE: ARG) is the largest U.S. distributor of industrial gases, medical gases, specialty gases and welding equipment. The firm is also one of the largest U.S. distributors of safety products, the largest U.S. producer of nitrous oxide and dry ice, the largest liquid carbon dioxide producer in the Southeast, and a leading distributor of process chemicals, refrigerants, and ammonia products. More than 14,000 employees work at over 1,100 locations, including branches, retail stores, gas fill plants, specialty gas labs, production facilities and distribution centers.

The firm surprised investors earlier in the week, when it reported fiscal Q4 EPS of 78 cents and revenues of $1.09 billion. Analysts had been looking for 73 cents and $1.07 billion. The CEO noted that strategic product categories (healthcare, research, environmental, food & beverage) posted 11% organic growth in the quarter. The EPS figure was a company record. Management also guided Q1 EPS to 79-81 cents (74 cent consensus) and FY09 EPS to $3.24-$3.40 ($3.10 consensus).

Coinstar (NASDAQ: CSTR) offers North American and U.K. retailers a range of storefront service and entertainment devices. These include coin counters, kiddie rides, bulk vending machines, skill-crane games and point-of-sale terminals. The firm also provides self-service DVD movie rental/purchase kiosks and provides money transfer services, prepaid wireless products, stored value cards, payroll cards and prepaid debit cards. Coinstar products and services are distributed through more than 53,000 retail stores. Corporate clients include Wal-Mart (NYSE: WMT), Kroger (NYSE: KR) and Walgreen (NYSE: WAG).

The company surprised the Street last week, when it reported Q1 EPS of 18 cents and revenues of $190.5 million. Analysts had been expecting four cents and $182.7 million. Management also guided Q2 EPS to 8-15 cents (12 cent consensus), Q2 revenues to $200-$210 million ($202.19M consensus), FY08 EPS to 60-75 cents (57 cent consensus) and FY08 revenues to $850-$900 million ($829.83M consensus). DA Davidson subsequently upgraded the stock to "buy".

Amkor Technology (NASDAQ: AMKR) is a leading provider of semiconductor assembly and test services. The firm offers semiconductor companies and electronics manufacturers a complete set of microelectronics manufacturing services, including die bonding, wire bonding, chip encapsulation, and verification of function, current, timing, and voltage. Clients include IBM (NYSE: IBM), Intel (NASDAQ: INTC) and Texas Instruments (NYSE: TXN).

The company surprised the Street last week, when it reported Q1 EPS of 36 cents and revenues of $699.5 million. Analysts had been looking for 26 cents and $684.3 million. The CEO attributed success to customer demand for wireless communications and networking applications. Management also guided Q2 EPS to 32-36 cents (28 cent consensus) and Q2 revenues to about $706-$720 million ($700.6M consensus).

Panera Bread Company (NASDAQ: PNRA) owns and franchises some 1,200 bakery-cafes, operating under the Panera Bread and Saint Louis Bread banners in 40 states. The stores offer specialty baked goods, made-to-order sandwiches, soups, salads and custom roasted coffees. They also provide free WiFi Internet access. Starbucks Corporation (NASDAQ: SBUX) is a major competitor.

The company pleased investors last week, when it reported Q1 EPS of 47 cents and revenues of $305 million. Analysts had been expecting 39 cents and $302.8 million. Management also guided Q2 EPS to 40-44 cents (39 cent consensus) and FY08 EPS to $2.00-$2.11 ($2.02 consensus). The press release noted, "Company-owned comparable stores sales growth is targeted at 4% to 5% for the year, with approximately 5% of retail pricing expected."